BioWorld

Sep. 18, 1996

View Archived Issues

OTHER NEWS TO NOTE

Read More

VASCULAR THERAPEUTICS RAISES $12.5M, PLANS FIRST TRIAL

Read More

WHY DIDN'T BIOWORLD TODAY PUBLISH OUR COMPANY'S NEWS?

Read More

IN HIGH-LOW GAME OF ANTI-HIV IL-2 DOSAGE, LOW WINS HANDS DOWN

Read More

36TH ANNUAL ICAAC CONFERENCE NEXSTAR TO FILE FOR FDA APPROVAL OF

Read More